HIV Vaccines

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A “preventive” vaccine would stop HIV infection occurring altogether, whereas a “therapeutic” vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, a therapeutic vaccine would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV.

  • HIV Vaccine Strategies
  • T cell-based vaccines
  • B cell-based vaccines
  • Innate & Mucosal Immunity
  • Viral Vaccine Vectors
  • Preventive HIV Vaccines
  • Innovations in HIV Vaccine Discovery
  • Emerging Clinical Trials
  • Challenges Facing AIDS Vaccine Development

Related Conference of HIV Vaccines

August 21-22, 2017

17th International Conference on Children Vaccines

Birmingham, UK
September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
July 27-28, 2017

19th International Vaccines & B2B Congress

Chicago, USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
November 30-December 01, 2017

23rd Global Vaccines & Vaccination Summit

Dubai, UAE

HIV Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in